Why the study?
Does catheter ablation improve imaging markers of tachycardia-induced cardiomyopathy in a patient with Wolff-Parkinson-White syndrome and atrial fibrillation?
Does catheter ablation improve imaging markers of tachycardia-induced cardiomyopathy in a patient with Wolff-Parkinson-White syndrome and atrial fibrillation?
Catheter ablation successfully treated tachycardia-induced cardiomyopathy and reversed left ventricular delayed enhancement on MRI in a patient with Wolff-Parkinson-White syndrome and atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Suggests reversibility of diffuse LV delayed enhancement after ablation in tachycardia-induced cardiomyopathy; leaves open generalizability beyond this case.
A 50-year-old man presented with general fatigue on exertion. Investigations revealed tachycardia-induced cardiomyopathy induced by Wolff-Parkinson-White syndrome and atrial fibrillation. He was successfully treated with catheter ablation. Cardiac magnetic resonance imaging revealed that delayed enhancement throughout the left ventricle disappeared within 2 months after ablation. (Level of Difficulty: Beginner.)
No takes yet. Share an insight, caveat, or question.
Miki et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: